WO2002088736A3 - Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel - Google Patents

Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel Download PDF

Info

Publication number
WO2002088736A3
WO2002088736A3 PCT/FR2002/001505 FR0201505W WO02088736A3 WO 2002088736 A3 WO2002088736 A3 WO 2002088736A3 FR 0201505 W FR0201505 W FR 0201505W WO 02088736 A3 WO02088736 A3 WO 02088736A3
Authority
WO
WIPO (PCT)
Prior art keywords
foetus
maternal blood
genetic
prenatal diagnosis
diagnosis method
Prior art date
Application number
PCT/FR2002/001505
Other languages
English (en)
Other versions
WO2002088736A2 (fr
Inventor
Patrizia Paterlini-Brechot
Original Assignee
Metagenex S A R L
Patrizia Paterlini-Brechot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8862866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002088736(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metagenex S A R L, Patrizia Paterlini-Brechot filed Critical Metagenex S A R L
Priority to EP02740785.7A priority Critical patent/EP1383926B1/fr
Priority to CA2452099A priority patent/CA2452099C/fr
Priority to ES02740785.7T priority patent/ES2543709T3/es
Priority to AU2002314224A priority patent/AU2002314224B2/en
Priority to JP2002585985A priority patent/JP4404553B2/ja
Publication of WO2002088736A2 publication Critical patent/WO2002088736A2/fr
Publication of WO2002088736A3 publication Critical patent/WO2002088736A3/fr
Priority to US10/695,744 priority patent/US7651838B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Abstract

La présente invention est relative à une nouvelle méthode de diagnostic prénatal non-invasive mise en oeuvre à partir d'un échantillon de sang maternel. Ladite méthode permet le diagnostic prénatal sur cellules foetales, épithéliales, non apoptotiques isolées du sang maternel après leur enrichissement par filtration, leur analyse morphologique ou immunologique et génétique. Les avantages de cette méthode sont en particulier son innocuité pour la mère ou le foetus et la très grande sensibilité et spécificité du diagnostic. Elle permet la détection précoce d'une anomalie génétique ou chromosomique du foetus, d'une pathologie génétique ou infectieuse (virale, bactérienne ou parasitaire) du foetus, d'un génotype précis, et en particulier du sexe génétique du foetus.
PCT/FR2002/001505 2001-04-30 2002-04-30 Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel WO2002088736A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP02740785.7A EP1383926B1 (fr) 2001-04-30 2002-04-30 Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
CA2452099A CA2452099C (fr) 2001-04-30 2002-04-30 Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
ES02740785.7T ES2543709T3 (es) 2001-04-30 2002-04-30 Procedimiento de diagnóstico prenatal en célula fetal aislada de sangre materna
AU2002314224A AU2002314224B2 (en) 2001-04-30 2002-04-30 Prenatal diagnosis method on isolated foetal cell of maternal blood
JP2002585985A JP4404553B2 (ja) 2001-04-30 2002-04-30 単離された母体血液の胎児細胞に対する出生前診断の方法
US10/695,744 US7651838B2 (en) 2001-04-30 2003-10-30 Prenatal diagnosis method on isolated foetal cell of maternal blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105824A FR2824144B1 (fr) 2001-04-30 2001-04-30 Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
FR01/05824 2001-04-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/695,744 Continuation US7651838B2 (en) 2001-04-30 2003-10-30 Prenatal diagnosis method on isolated foetal cell of maternal blood

Publications (2)

Publication Number Publication Date
WO2002088736A2 WO2002088736A2 (fr) 2002-11-07
WO2002088736A3 true WO2002088736A3 (fr) 2003-09-25

Family

ID=8862866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/001505 WO2002088736A2 (fr) 2001-04-30 2002-04-30 Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel

Country Status (8)

Country Link
US (1) US7651838B2 (fr)
EP (1) EP1383926B1 (fr)
JP (1) JP4404553B2 (fr)
AU (1) AU2002314224B2 (fr)
CA (1) CA2452099C (fr)
ES (1) ES2543709T3 (fr)
FR (1) FR2824144B1 (fr)
WO (1) WO2002088736A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107502668A (zh) * 2017-09-23 2017-12-22 上海五色石医学研究股份有限公司 一种人Y染色体标签位点sY1291的检测方法及其应用

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
US7993908B2 (en) 2001-07-17 2011-08-09 Parsortix, Inc. Microstructure for particle and cell separation, identification, sorting, and manipulation
AU2003216175A1 (en) * 2002-02-04 2003-09-02 Colorado School Of Mines Laminar flow-based separations of colloidal and cellular particles
EP2359689B1 (fr) 2002-09-27 2015-08-26 The General Hospital Corporation Dispositif microfluidique pour la séparation de cellules et usage du dispositif
ES2784011T3 (es) 2002-10-16 2020-09-21 Streck Inc Procedimiento y dispositivo para recoger y preservar las células para su análisis
EP1604184A4 (fr) * 2003-02-27 2010-10-27 Stephen A Lesko Evaluation normalisee de l'efficacite therapeutique fondee sur des marqueurs biologiques cellulaires
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20050282293A1 (en) * 2004-03-03 2005-12-22 Cosman Maury D System for delivering a diluted solution
CA2557819A1 (fr) * 2004-03-03 2005-09-15 The General Hospital Corporation Dispositif magnetique destine a l'isolation de cellules et de biomolecules dans un environnement microfluidique
US20060121624A1 (en) * 2004-03-03 2006-06-08 Huang Lotien R Methods and systems for fluid delivery
US8024128B2 (en) * 2004-09-07 2011-09-20 Gene Security Network, Inc. System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data
FI20055007A0 (fi) * 2005-01-05 2005-01-05 Wallac Oy Menetelmä näytteen analysoimiseksi
US20060171846A1 (en) * 2005-01-10 2006-08-03 Marr David W M Microfluidic systems incorporating integrated optical waveguides
FR2880897B1 (fr) * 2005-01-18 2010-12-17 Inst Nat Sante Rech Med Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose
FR2883488B1 (fr) * 2005-03-24 2010-12-10 Inst Nat Sante Rech Med Procede et dispositif pour separer par filtration verticale des particules biologiques contenues dans un liquide
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026413A1 (en) * 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
EP1874920A4 (fr) * 2005-04-05 2009-11-04 Cellpoint Diagnostics Dispositifs et procédés permettant d'enrichir et de modifier des cellules tumorales circulantes et d'autres particules
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP2703499A1 (fr) * 2005-06-02 2014-03-05 Fluidigm Corporation Analyse utilisant des dispositifs de séparation microfluidiques pour générer des échantillons comprenant une seule cellule
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070027636A1 (en) * 2005-07-29 2007-02-01 Matthew Rabinowitz System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8515679B2 (en) 2005-12-06 2013-08-20 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070178501A1 (en) * 2005-12-06 2007-08-02 Matthew Rabinowitz System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059718A1 (en) * 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
EP3599609A1 (fr) * 2005-11-26 2020-01-29 Natera, Inc. Système et procédé pour nettoyer des données génétiques bruyantes et au moyen de données pour faire des prédictions
US20090220933A1 (en) * 2005-12-08 2009-09-03 Fcmb Aps Detection of fetal cells from maternal blood
US9487812B2 (en) 2012-02-17 2016-11-08 Colorado School Of Mines Optical alignment deformation spectroscopy
US9878326B2 (en) * 2007-09-26 2018-01-30 Colorado School Of Mines Fiber-focused diode-bar optical trapping for microfluidic manipulation
US8119976B2 (en) * 2007-07-03 2012-02-21 Colorado School Of Mines Optical-based cell deformability
US9885644B2 (en) 2006-01-10 2018-02-06 Colorado School Of Mines Dynamic viscoelasticity as a rapid single-cell biomarker
DE602007014335D1 (de) * 2006-02-28 2011-06-16 Univ Louisville Res Found Erkennung von chromosomabnormalitäten im fötus mit hilfe der tandem-einzelnukleotid-polymorphismen
US8609338B2 (en) * 2006-02-28 2013-12-17 University Of Louisville Research Foundation, Inc. Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
US20100184044A1 (en) 2006-02-28 2010-07-22 University Of Louisville Research Foundation Detecting Genetic Abnormalities
US20100184043A1 (en) * 2006-02-28 2010-07-22 University Of Louisville Research Foundation Detecting Genetic Abnormalities
EP3406736B1 (fr) * 2006-06-14 2022-09-07 Verinata Health, Inc. Procédés pour le diagnostic d'anomalies fétales
WO2009035447A1 (fr) * 2006-06-14 2009-03-19 Living Microsystems, Inc. Diagnostic d'anomalies fœtales par une analyse par hybridation génomique comparative
EP2589668A1 (fr) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse de cellules rares utilisant la division d'échantillons et les marqueurs d'ADN
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) * 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
WO2008111990A1 (fr) * 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Analyse de cellules rares par division d'échantillon et utilisation de marqueurs d'adn
US20080007838A1 (en) * 2006-07-07 2008-01-10 Omnitech Partners, Inc. Field-of-view indicator, and optical system and associated method employing the same
EP3032259B1 (fr) * 2007-05-01 2020-04-15 Tel Hashomer Medical Research Infrastructure and Services Ltd. Procédés de détection des cellules trophoblastiques dans le sang maternel sur la base de la cytokératine-7
US10722250B2 (en) 2007-09-04 2020-07-28 Colorado School Of Mines Magnetic-field driven colloidal microbots, methods for forming and using the same
US20090062828A1 (en) * 2007-09-04 2009-03-05 Colorado School Of Mines Magnetic field-based colloidal atherectomy
AP3322A (en) * 2007-12-05 2015-06-30 Zyomyx Inc Cell assay kit and method
EP3779444A1 (fr) 2008-01-18 2021-02-17 President and Fellows of Harvard College Procédés de détection de signatures de maladies ou d'états dans des fluides corporels
US20110033862A1 (en) * 2008-02-19 2011-02-10 Gene Security Network, Inc. Methods for cell genotyping
US20110092763A1 (en) * 2008-05-27 2011-04-21 Gene Security Network, Inc. Methods for Embryo Characterization and Comparison
US20100159506A1 (en) * 2008-07-25 2010-06-24 Cellscape Corporation Methods and systems for genetic analysis of fetal nucleated red blood cells
CN104732118B (zh) 2008-08-04 2017-08-22 纳特拉公司 等位基因调用和倍性调用的方法
SI2334812T1 (sl) 2008-09-20 2017-05-31 The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
ES2649572T3 (es) 2009-02-18 2018-01-12 Streck Inc. Conservación de ácidos nucleicos fuera de las células
ES2640776T3 (es) 2009-09-30 2017-11-06 Natera, Inc. Métodos para denominar de forma no invasiva ploidía prenatal
US20110111410A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in intact cells within a blood sample
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
CA2798758C (fr) 2010-05-18 2019-05-07 Natera, Inc. Procedes de classification de ploidie prenatale non invasive
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EA201390149A1 (ru) 2010-07-23 2013-08-30 Президент Энд Феллоуз Оф Гарвард Колледж Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
CA2806293A1 (fr) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Procedes de detection de maladies/pathologies auto-immunes ou liees au systeme immunitaire
CN103119179A (zh) 2010-07-23 2013-05-22 哈佛大学校长及研究员协会 用于检测体液中的疾病或病症标记的方法
EP2596353A4 (fr) 2010-07-23 2014-01-15 Harvard College Méthodes de dépistage de maladies ou d'affections prénatales ou liées à la grossesse
AU2011348100B2 (en) 2010-12-22 2016-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
CA2824387C (fr) 2011-02-09 2019-09-24 Natera, Inc. Procedes de classification de ploidie prenatale non invasive
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
CN104023551A (zh) * 2011-11-04 2014-09-03 生物辐射实验室股份有限公司 细胞组分的同时纯化
US9766207B2 (en) 2011-11-04 2017-09-19 Bio-Rad Laboratories, Inc. Affinity methods and compositions employing electronic control of pH
WO2013123425A1 (fr) 2012-02-15 2013-08-22 Bio-Rad Laboratories, Inc. Régulation électronique de ph et de force ionique
US9321012B2 (en) 2012-04-04 2016-04-26 Bio-Rad Laboratories, Inc. Electronic protein fractionation
CN104471077B (zh) 2012-05-21 2017-05-24 富鲁达公司 颗粒群的单颗粒分析
EP3745126A1 (fr) * 2012-05-24 2020-12-02 Assistance Publique - Hôpitaux de Paris Procédé pour multi-analyses de cellules rares extraites de ou isolées par filtration à partir d'échantillons biologiques
CA2876731A1 (fr) * 2012-06-15 2013-12-19 Harry Stylli Procedes de detection de maladies ou d'etats
EP2684947A1 (fr) * 2012-07-09 2014-01-15 Biocartis SA Méthode de filtration d'un échantillon biologique
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (fr) 2013-03-09 2014-10-09 Harry Stylli Procédés de détection du cancer de la prostate
US9631179B2 (en) * 2013-03-15 2017-04-25 Angle North America, Inc. Methods for segregating particles using an apparatus with a size-discriminating separation element having an elongate leading edge
EP4136972A1 (fr) 2013-07-24 2023-02-22 Streck, Inc. Compositions et méthodes de stabilisation de cellules tumorales circulantes
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
FR3012974B1 (fr) 2013-11-12 2016-01-15 Biocarecell Dispositif a filtration amelioree pour retenir des cellules contenues dans un echantillon liquide.
EP3134541B1 (fr) 2014-04-21 2020-08-19 Natera, Inc. Détection des ploïdies dans des segments chromosomiques en cancer
CN106661633A (zh) * 2014-09-11 2017-05-10 富士胶片株式会社 胎儿染色体有无非整倍性的检测方法
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
WO2018067517A1 (fr) 2016-10-04 2018-04-12 Natera, Inc. Procédés pour caractériser une variation de nombre de copies à l'aide d'un séquençage de ligature de proximité
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
EP3585889A1 (fr) 2017-02-21 2020-01-01 Natera, Inc. Compositions, procédés, et kits d'isolement d'acides nucléiques
KR101926117B1 (ko) * 2017-08-18 2018-12-06 주식회사 싸이토젠 안드로겐 수용체의 변이체 기반 전립선암환자 스크리닝 방법
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN110117571B (zh) * 2019-05-08 2023-01-31 南方医科大学南方医院 无创获取胎儿稀有细胞的试剂盒及其方法
CN110211654A (zh) * 2019-05-30 2019-09-06 湖南自兴智慧医疗科技有限公司 一种自动隐藏性别信息的核型检测系统及方法
SG11202113242QA (en) 2019-06-07 2021-12-30 Arcedi Biotech Aps Isolation of fetal cells using facs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501954A (en) * 1994-06-13 1996-03-26 Genzyme Corporation Method of detecting cellular material
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
WO1999015892A1 (fr) * 1997-09-22 1999-04-01 Flinders Technologies Pty. Ltd. Enrichissement du sang peripherique maternel en cellules trophoblastiques et identification desdites cellules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721098A (en) * 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
ATE161960T1 (de) 1988-12-06 1998-01-15 Flinders Technologies Pty Ltd Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
FR2657543B1 (fr) * 1990-01-26 1992-12-18 Biocom Sa Dispositif modulaire pour le recueil, l'incubation, la filtration d'echantillons multiples.
US5714325A (en) 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
US5580724A (en) 1994-03-25 1996-12-03 Board Of Regents, The University Of Texas System Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis
US5646004A (en) 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
FR2748569B1 (fr) 1996-05-07 1998-08-07 Biocom Sa Procede et installation de separation de particules magnetiques dans un fluide pour l'analyse biologique, et application dudit procede
FR2782730B1 (fr) 1998-08-25 2002-05-17 Biocom Sa Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
US5501954A (en) * 1994-06-13 1996-03-26 Genzyme Corporation Method of detecting cellular material
WO1999015892A1 (fr) * 1997-09-22 1999-04-01 Flinders Technologies Pty. Ltd. Enrichissement du sang peripherique maternel en cellules trophoblastiques et identification desdites cellules

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIANCHI DIANA W: "Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis.", BRITISH JOURNAL OF HAEMATOLOGY, vol. 105, no. 3, June 1999 (1999-06-01), pages 574 - 583, XP002186869, ISSN: 0007-1048 *
VONA GIOVANNA ET AL: "Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood.", AMERICAN JOURNAL OF PATHOLOGY. UNITED STATES JAN 2002, vol. 160, no. 1, January 2002 (2002-01-01), pages 51 - 58, XP002236986, ISSN: 0002-9440 *
VONA GIOVANNA ET AL: "Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells.", AMERICAN JOURNAL OF PATHOLOGY, vol. 156, no. 1, January 2000 (2000-01-01), pages 57 - 63, XP002186868, ISSN: 0002-9440 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107502668A (zh) * 2017-09-23 2017-12-22 上海五色石医学研究股份有限公司 一种人Y染色体标签位点sY1291的检测方法及其应用

Also Published As

Publication number Publication date
US7651838B2 (en) 2010-01-26
EP1383926A2 (fr) 2004-01-28
ES2543709T3 (es) 2015-08-21
JP4404553B2 (ja) 2010-01-27
US20050049793A1 (en) 2005-03-03
AU2002314224B2 (en) 2007-08-02
JP2004533243A (ja) 2004-11-04
CA2452099C (fr) 2017-05-09
EP1383926B1 (fr) 2015-05-06
FR2824144B1 (fr) 2004-09-17
WO2002088736A2 (fr) 2002-11-07
FR2824144A1 (fr) 2002-10-31
CA2452099A1 (fr) 2002-11-07

Similar Documents

Publication Publication Date Title
WO2002088736A3 (fr) Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
DK1439897T3 (da) Fremgangsmåder til adskillelse af sjældne celler fra væskeprøver
AU2487095A (en) Non-invasive method for isolation and detection of foetal DNA
EP2261658A3 (fr) Diagnostique des infections sur la base de IP-10
DK0994963T4 (da) Noninvasiv prænatal diagnose
WO2007059492A3 (fr) Procede de detection du papilomavirus humain (hpv) et application dudit procede au cancer cervical
EP2612927A3 (fr) Marqueurs pour le diagnostic et la surveillance prénatale
DK107391A (da) Isolering af foetale celler fra moderblod for at muliggoere diagnose foer foedslen
WO2003042788A3 (fr) Systeme de suivi d'echantillons biologiques
Omalu et al. Prevalence of congenital malaria in Minna, north central Nigeria
WO2002096266A3 (fr) Methode et systeme d'analyse optique permettant de detecter un etat pathologique
HUP0401953A2 (hu) Biotinszármazékok
Dieudonné et al. Biochemical analysis of the sperm and infertility
US11143655B1 (en) Systems and methods for assay processing
WO2002074986A3 (fr) Test sanguin de diagnostic precoce pre-symptomatique pour les encephalopathies
CN213240182U (zh) 一种用于检测双份生物样本来源同一性的快速检测试纸
Warburg Diagnostic precision in microphthalmos and coloboma of heterogeneous origin
CN109001469A (zh) 一种Tau蛋白检测试剂条及其应用
Lanza Issue Highlights—January 2013
Loesch FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male.
AU2003294932A1 (en) Method for the detection of cancer
Zuberi et al. Low dose, short-term, triple therapy for Helicobacter pylori associated peptic ulcer
Imilda et al. Bacterial pneumonia score to identify bacterial pneumonia
Yoeli-Ullman et al. 216: Prenatal diagnosis of fetal cytomegalovirus infection in 543 cases of suspected maternal non-primary infection
Tam et al. 214: Identification of hepatitis C virus in cervico-vaginal secretions of infected women

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2452099

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002314224

Country of ref document: AU

Ref document number: 10695744

Country of ref document: US

Ref document number: 2002585985

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002740785

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002740785

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002314224

Country of ref document: AU